Free Trial
→ Trump’s national nightmare is here (From Porter & Company) (Ad)tc pixel

Eurofins Scient (OTCMKTS:ERFSF) Stock Price Up 0.5% - Still a Buy?

Written by MarketBeat
October 20, 2025
Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scient shares saw a modest increase of 0.5%, trading at $74.53 with a higher volume of 1,235 shares compared to the average.
  • Analysts have mostly rated Eurofins Scient as a "Hold"** or a "Strong Buy"**, indicating a mixed outlook on the stock's future performance.
  • The company's financial metrics show a debt-to-equity ratio of 0.77 and a current ratio of 1.26, suggesting a stable financial position.
  • Five stocks we like better than Eurofins Scient.

Shares of Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) shot up 0.5% during mid-day trading on Monday . The stock traded as high as $74.99 and last traded at $74.53. 1,235 shares were traded during trading, an increase of 16% from the average session volume of 1,060 shares. The stock had previously closed at $74.14.

Analyst Upgrades and Downgrades

Separately, Citigroup reiterated a "neutral" rating on shares of Eurofins Scient in a research report on Friday, July 25th. One research analyst has rated the stock with a Strong Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold".

Check Out Our Latest Research Report on ERFSF

Eurofins Scient Trading Up 0.5%

The company's 50 day moving average price is $75.22 and its two-hundred day moving average price is $69.88. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.